13125 Berlin, de
Eckert & Ziegler Classified in California as Essential Business
In other locations and the European Union, where the remainders of Eckert & Ziegler’s production sites are located, so far no closing orders have been issued. In the opinion of the Management Board, however, the situation in almost all places is similar to California, not only for the live saving cancer treatment devices or radiopharmaceuticals that are manufactured in these other locations, but also for services and industrial products. Cobalt irradiation sources, seemingly just a technical component, are for example needed for the gamma sterilization of medical devices and lately see a soaring demand.
“The group’s economic performance will nevertheless be affected by the global governmental reactions to the corona crisis” cautions the CEO of the group, Dr. Andreas Eckert. “The turmoil caused by social thinning-out measures, curfews, school closures, or travel restrictions has already led to the delay or cancellation of orders and increased cost. Furthermore, the widespread paralyzation of public institutions and the interruptions of well-established routines may influence the ability to implement countermeasures swiftly.”
The group will provide further details on the 2020 outlook together with the details of the 2019 annual report on 31 March 2020.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.